|
- R D Antibody Discovery Partner | Fusion Antibodies
Fusion Antibodies offer a complete end-to-end service from antigen design to cell line development R D Antibody Discovery Partner
- About Us - Fusion Antibodies
Fusion Antibodies are world leaders with over 20 years experience in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development
- Antibody Discovery | Fusion Antibodies
Antibody Discovery projects are built with a range of antigen design options, immunisation scheduling, host species and screening strategies
- Contact Us - Fusion Antibodies
Contact us about Antibody Humanization Optimize your antibody to be the best Contact us to start a project
- Fusion Antibodies News
Fusion Antibodies, pre-clinical antibody discovery and development experts and BioTickle, their exclusive distributor in India, are providing local biopharmaceutical organisations with access to invaluable unique biopharmaceutical development capabilities
- LSE:FAB - Deep Dive: The Opti Library
In this episode, Chief Scientific Officer Richard Buick unpacks the science and significance of Fusion’s Opti Library, a cornerstone of their antibody discovery toolkit Richard explains what makes the Opti Library unique: a highly diverse, carefully curated collection of antibody sequences designed to accelerate the identification of promising therapeutic candidates He highlights how the
- LSE:FAB - Company Update Presentation - May 2025
In the latest investor presentation CEO Dr Adrian Kinkaid and interim CFO Stephen Smyth provided a comprehensive overview of Fusion Antibodies performance and strategic direction for the financial year ended 31 March 2025 Key highlights include:Strong Revenue Growth: Unaudited annual revenues rose by 71% to £1 96 million driven by robust performance across both discovery and diagnostic
- Home | Fusion Antibodies plc investor hub
View share price, top shareholders, your shareholding, and interact with announcements for Fusion Antibodies plc
|
|
|